 <h1>Sildenafil Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of sildenafil include:</b> dyspepsia, headache, visual disturbance, and flushing. <b>Other side effects include:</b> epistaxis, insomnia, nasal congestion, and rhinitis.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to sildenafil: oral powder for suspension, oral tablet</i></p><p>Other dosage forms:</p><ul><li>intravenous solution</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, sildenafil may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking sildenafil:</p><p>
<i>Less common</i>
</p><ul>
<li>Bladder pain</li>
<li>burning feeling in the chest or stomach</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>cloudy or bloody urine</li>
<li>dizziness</li>
<li>increased frequency of urination</li>
<li>indigestion</li>
<li>pain on urination</li>
<li>stomach upset</li>
<li>tenderness in the stomach area</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Abnormal vision</li>
<li>anxiety</li>
<li>behavior change similar to drunkenness</li>
<li>bleeding of the eye</li>
<li>blurred vision</li>
<li>bone pain</li>
<li>breast enlargement</li>
<li>chest pain</li>
<li>chills</li>
<li>cold sweats</li>
<li>confusion</li>
<li>convulsions (seizures)</li>
<li>cool and pale skin</li>
<li>deafness or hearing loss</li>
<li>decrease in amount of urine or the frequency of urination</li>
<li>decreased vision</li>
<li>difficulty in concentrating</li>
<li>dizziness or lightheadedness, especially when getting up suddenly from a lying or sitting position</li>
<li>double vision</li>
<li>drowsiness</li>
<li>dry eyes</li>
<li>dry mouth</li>
<li>dryness, redness, scaling, or peeling of the skin</li>
<li>excessive hunger</li>
<li>eye pain</li>
<li>fainting or faintness</li>
<li>fast, irregular, or pounding heartbeat</li>
<li>feeling of something in the eye</li>
<li>fever or chills</li>
<li>headache (severe or continuing)</li>
<li>increase in the size of the pupil</li>
<li>increased sweating</li>
<li>increased thirst</li>
<li>lower back or side pain</li>
<li>migraine headache</li>
<li>nausea (severe or continuing)</li>
<li>nervousness</li>
<li>nightmares</li>
<li>numbness of the hands</li>
<li>painful, swollen joints</li>
<li>prolonged, painful erection of penis</li>
<li>redness, burning, or swelling of the eyes</li>
<li>redness, itching, or tearing of the eyes</li>
<li>restless sleep</li>
<li>seeing shades of colors differently than before</li>
<li>sensitivity to light</li>
<li>shakiness</li>
<li>skin lesions with swelling</li>
<li>skin paleness</li>
<li>skin rash, hives, or itching</li>
<li>skin ulcers</li>
<li>slurred speech</li>
<li>sore throat</li>
<li>sudden weakness</li>
<li>swelling of the face, hands, feet, or lower legs</li>
<li>trouble breathing</li>
<li>twitching of the muscles</li>
<li>unusual feeling of burning or stinging of the skin</li>
<li>unusual tiredness or weakness</li>
<li>vision changes</li>
<li>vision loss, temporary</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blindness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of sildenafil may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Aches or pains in the muscles</li>
<li>bloody nose</li>
<li>diarrhea</li>
<li>difficult or labored breathing</li>
<li>flushing</li>
<li>headache</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>redness of the skin</li>
<li>sneezing</li>
<li>stomach discomfort following meals</li>
<li>stuffy or runny nose</li>
<li>trouble sleeping</li>
<li>unusually warm skin</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>abnormal dreams</li>
<li>anxiety</li>
<li>clumsiness or unsteadiness</li>
<li>cough</li>
<li>diarrhea or stomach cramps (severe or continuing)</li>
<li>difficulty in swallowing</li>
<li>ear pain</li>
<li>increased amount of saliva</li>
<li>increased skin sensitivity</li>
<li>lack of coordination</li>
<li>loss of bladder control</li>
<li>mental depression</li>
<li>nausea</li>
<li>numbness or tingling of the hands, legs, or feet</li>
<li>rectal bleeding</li>
<li>redness or irritation of the tongue</li>
<li>redness, soreness, swelling, or bleeding of the gums</li>
<li>ringing or buzzing in the ears</li>
<li>sensation of motion, usually whirling, either of one's self or of one's surroundings</li>
<li>sexual problems in men (continuing), including failure to experience a sexual orgasm</li>
<li>sleepiness</li>
<li>sores in the mouth and on the lips</li>
<li>tense muscles</li>
<li>trembling and shaking</li>
<li>vomiting</li>
<li>waking to urinate at night</li>
<li>worsening of asthma</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sildenafil: intravenous solution, oral powder for reconstitution, oral tablet</i></p><h3>General</h3><p>The most common adverse reactions reported in clinical trials are headache, flushing, dyspepsia, abnormal vision, nasal congestion, back pain, myalgia, nausea, dizziness, and rash.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Flushing (10%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Heart rate increased, palpitations, tachycardia, hypertension, hypotension</p>
<p><b>Rare</b> (less than 0.1%): Myocardial infarction, atrial fibrillation, sudden cardiac death, ventricular arrhythmia, unstable angina</p>
<p><b>Frequency not reported</b>: Ventricular arrhythmia, sudden cardiac death, angina pectoris, AV block, tachycardia, palpitation, hypotension, postural hypotension, myocardial ischemia, cerebral thrombosis, cardiac arrest, heart failure, abnormal electrocardiogram, cardiomyopathy, shock</p>
<p><b>Postmarketing reports</b>: Serious cardiovascular, cerebrovascular, and vascular events, including myocardial infarction; sudden cardiac death; ventricular arrhythmia; cerebrovascular hemorrhage; transient ischemic attack; hypertension; subarachnoid, intracerebral, and pulmonary hemorrhage have been reported in temporal association with the use of this drug.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dyspepsia (up to 17%), diarrhea</p>
<p><b>Common</b> (1% to 10%): Nausea, vomiting, dry mouth, gastritis, gastroesophageal reflux disease, hemorrhoids, abdominal distension</p>
<p><b>Rare</b> (less than 0.1%): Oral hypoesthesia</p>
<p><b>Frequency not reported</b>: Glossitis, colitis, dysphagia, gastroenteritis, esophagitis, stomatitis, gingivitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Pain in extremity</p>
<p><b>Common</b> (1% to 10%): Back pain, myalgia</p>
<p><b>Frequency not reported</b>: Arthritis, arthrosis, myalgia, tendon rupture, tenosynovitis, bone pain, myasthenia, synovitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 28%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, migraine, tremor, paresthesia, burning sensation</p>
<p><b>Uncommon</b> (0.1% to 1%): Somnolence, hypoesthesia</p>
<p><b>Rare</b> (less than 0.1%): Cerebrovascular accident, syncope</p>
<p><b>Frequency not reported</b>: Transient ischemic attack, seizure, seizure recurrence, ataxia, hypertonia, neuralgia, neuropathy, paresthesia, somnolence, reflexes decreased</p>
<p><b>Postmarketing reports</b>: Transient global amnesia<sup>[Ref]</sup></p><h3>Ocular</h3><p>This drug has lesser affinity for isoenzyme PDE6, an enzyme found in the retina.  This lower selectivity is thought to be the basis for abnormalities related to color vision observed with higher doses or plasma levels.</p>
<p></p>
<p>Nonarteritic anterior ischemic optic neuropathy developed in one eye within minutes to hours after ingestion of sildenafil.  Four of the five patients had no vascular risk factors for ischemic optic neuropathy.</p>
<p></p>
<p>-Abnormal Vision: Mild to moderate and transient, predominantly color tinge to vision, but also increased sensitivity to light, or blurred vision.</p>
<p>-Visual color distortions: Chloropsia, chromatopsia, cyanopsia, erythropsia and xanthopsia </p>
<p>-Lacrimation disorders: Dry eye, lacrimal disorder and lacrimation increased<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Abnormal vision (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Visual color distortion, retinal hemorrhage, visual impairment, vision blurred, photophobia, chromatopsia, cyanopsia, eye irritation, ocular hyperemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Conjunctival disorders, eye disorders, eye pain, lacrimation disorders, visual acuity reduced, diplopia, abnormal sensation in eye, photopsia, visual brightness, conjunctivitis</p>
<p><b>Rare</b> (less than 0.1%): Retinal hemorrhage, arteriosclerotic retinopathy, retinal disorder, glaucoma, visual field defect, myopia, asthenopia, vitreous floaters, iris disorder, mydriasis, halo vision, eye edema, eye swelling, eyelid edema, scleral discoloration</p>
<p><b>Frequency not reported</b>: Non-arteritic anterior ischemic optic neuropathy (NAION), retinal vascular occlusion, visual field defect, cataract<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Pharyngitis (18%), rhinitis</p>
<p><b>Common</b> (1% to 10%): Nasal congestion, epistaxis, cough</p>
<p><b>Uncommon</b> (0.1% to 1%): Sinus congestion</p>
<p><b>Rare</b> (less than 0.1%): Throat tightness, nasal edema, nasal dryness</p>
<p><b>Frequency not reported</b>: Asthma, dyspnea, laryngitis, pharyngitis, sinusitis, bronchitis, sputum increased, cough increased<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash, alopecia, erythema, night sweats </p>
<p><b>Frequency not reported</b>: Steven-Johnson syndrome (SJS), toxic epidermal necrolysis(TEN), urticaria, herpes simplex, pruritus, sweating, skin ulcer, contact dermatitis, exfoliative dermatitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia</p>
<p><b>Frequency not reported</b>: Leukopenia</p>
<p><b>Postmarketing reports</b>: In patients with pulmonary arterial hypertension (secondary to sickle cell disease) taking Revatio (R), vaso-occlusive crises requiring hospitalization were more commonly reported.  The clinical relevance of this finding in male patients treated with sildenafil for erectile dysfunction is unknown.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Fluid retention</p>
<p><b>Frequency not reported</b>: Thirst, edema, gout, unstable diabetes, hyperglycemia, hyperuricemia, hypoglycemic reaction, hypernatremia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Cellulitis, influenza, bronchitis, sinusitis, rhinitis, gastroenteritis, vertigo, pyrexia</p>
<p><b>Uncommon</b> (0.1% to 1%): Tinnitus, chest pain, fatigue, gynecomastia</p>
<p><b>Rare</b> (less than 0.1%): Deafness, irritability</p>
<p><b>Frequency not reported</b>: Sudden hearing loss, edema, face edema, peripheral edema, pain, chills accidental fall, accidental injury<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, anxiety</p>
<p><b>Frequency not reported</b>: Abnormal dreams, depression<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Penile hemorrhage, hematospermia</p>
<p><b>Frequency not reported</b>: Priapism, prolonged erection, increased erection, cystitis, nocturia, urinary frequency, urinary incontinence, abnormal ejaculation, genital edema, anorgasmia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Hematuria<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Hypersensitivity reactions, including rash and urticaria<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Liver function tests abnormal<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Viagra (sildenafil)." Pfizer US Pharmaceuticals, New York, NY. </p><p id="ref_3">3. "Product Information. Revatio (sildenafil)." Pfizer U.S. Pharmaceuticals Group, New York, NY. </p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_5">5. Conti CR, Pepine CJ, Sweeney M "Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease." Am J Cardiol 83 (1999): c29-34</p><p id="ref_6">6. Malozowski S, Sahlroot JT "Hemodynamic effects of sildenafil." N Engl J Med 343 (2000): 967-8</p><p id="ref_7">7. Arruda-Olson AM,  Pellikka PA "Appropriate use of exercise testing prior to administration of drugs for treatment of erectile dysfunction." Herz 28 (2003): 291-7</p><p id="ref_8">8. Tran D,  Howes LG "Cardiovascular safety of sildenafil." Drug Saf 26 (2003): 453-60</p><p id="ref_9">9. Stanopoulos I,  Hatzichristou D,  Tryfon S,  Tzortzis V,  Apostolidis A,  Argyropoulou P "Effects of sildenafil on cardiopulmonary responses during stress." J Urol 169 (2003): 1417-21</p><p id="ref_10">10. Kloner RA "Cardiovascular risk and sildenafil." Am J Cardiol 86 (2000): f57-61</p><p id="ref_11">11. Feenstra J, vanDriePierik RJHM, Lacle CF, Stricker BHC "Acute myocardial infarction associated with sildenafil." Lancet 352 (1998): 957-8</p><p id="ref_12">12. McLeod AL,  McKenna CJ,  Northridge DB "Myocardial infarction following the combined recreational use of Viagra and cannabis." Clin Cardiol 25 (2002): 133-4</p><p id="ref_13">13. Kloner RA, Zusman RM "Cardiovascular effects of sildenafil citrate and recommendations for its use." Am J Cardiol 84 (1999): n11-7</p><p id="ref_14">14. Webster LJ,  Michelakis ED,  Davis T,  Archer SL "Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial." Arch Intern Med 164 (2004): 514-20</p><p id="ref_15">15. Khandheria BK "Erection, erectile dysfunction: what has heart got to do with it?" Herz 28 (2003): 275-6</p><p id="ref_16">16. Zusman RM "Cardiovascular data on sildenafil citrate - Introduction." Am J Cardiol 83 (1999): c1-2</p><p id="ref_17">17. Jackson G "Treatment of erectile dysfunction in patients with cardiovascular disease : guide to drug selection." Drugs 64 (2004): 1533-45</p><p id="ref_18">18. Arruda-Olson AM,  Mahoney DW,  Nehra A,  Leckel M,  Pellikka PA "Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial." JAMA 287 (2002): 719-25</p><p id="ref_19">19. Moreira SG, Brannigan RE, Spitz A, Orejuela FJ, Lipshultz LI, Kim ED "Side-effect profile of sildenafil citrate (Viagra) in clinical practice." Urology 56 (2000): 474-6</p><p id="ref_20">20. McMahon CG, Smali R, Johnson H "Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction." J Urol 164 (2000): 1192-6</p><p id="ref_21">21. Brindis RG,  Kloner RA "Sildenafil in patients with cardiovascular disease." Am J Cardiol 92(9 Suppl) (2003): 26-36</p><p id="ref_22">22. Israilov S,  Baniel J,  Shmueli J, et al. "Treatment program for erectile dysfunction in patients with cardiovascular diseases." Am J Cardiol 93 (2004): 689-93</p><p id="ref_23">23. Montorsi F, McDermott TED, Morgan R, Olsson A, Schultz A, Kirkeby HJ, Osterloh IH "Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies." Urology 53 (1999): 1011-8</p><p id="ref_24">24. Goldenberg MM "Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction." Clin Ther 20 (1998): 1033-48</p><p id="ref_25">25. Zusman RM, Morales A, Glasser DB, Osterloh IH "Overall cardiovascular profile of sildenafil citrate." Am J Cardiol 83 (1999): c35-44</p><p id="ref_26">26. Egan RA,  Pomeranz H "Transient ischemic attack an stroke associated with sildenafil (Viagra) use." Neurology 59 (2002): 293-4</p><p id="ref_27">27. Awan GM, Calderon E, Dawood G, Alpert MA "Acute, symptomatic atrial fibrillation after sildenafil citrate therapy in a patient with hypertrophic obstructive cardiomyopathy." Am J Med Sci 320 (2000): 69-71</p><p id="ref_28">28. Bocchi EA,  Guimaraes G,  Mocelin A,  Bacal F,  Bellotti G,  Ramires JF "Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction." Circulation 106 (2002): 1097-103</p><p id="ref_29">29. Dunn N "Cardiovascular events in users of sildenafil - Paper does not provide any reassurance." Br Med J 323 (2001): 50-1</p><p id="ref_30">30. Bosch X "Sildenafil's effects extended to additional organs." Lancet 355 (2000): 631</p><p id="ref_31">31. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA "Oral sildenafil in the treatment of erectile dysfunction." N Engl J Med 338 (1998): 1397-404</p><p id="ref_32">32. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ "Sildenafil, a novel effective oral therapy for male erectile dysfunction." Br J Urol 78 (1996): 257-61</p><p id="ref_33">33. PadmaNathan H, Steers WD, Wicker PA "Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: A double-blind, placebo-controlled study of 329 patients." Int J Clin Pract 52 (1998): 375-9</p><p id="ref_34">34. Bortolotti M, Mari C, Lopilato C, Porrazzo G, Miglioli M "Effects of sildenafil on esophageal motility of patients with idiopathic achalasia." Gastroenterology 118 (2000): 253-7</p><p id="ref_35">35. Gilad R,  Lampl Y,  Eshel Y,  Sadeh M "Tonic-clonic seizures in patients taking sildenafil." BMJ 325 (2002): 869</p><p id="ref_36">36. Savitz SA,  Caplan LR "Transient global amnesia after sildenafil (Viagra) use." Neurology 59 (2002): 778</p><p id="ref_37">37. Marmor MF "Sildenafil (Viagra) and ophthalmology." Arch Ophthalmol 117 (1999): 518-9</p><p id="ref_38">38. Egan R, Pomeranz H "Sildenafil (Viagra) associated anterior ischemic optic neuropathy." Arch Ophthalmol 118 (2000): 291-2</p><p id="ref_39">39. Vobig MA "Retinal side-effects of sildenafil." Lancet 353 (1999): 1442</p><p id="ref_40">40. Boshier A,  Pambakian N,  Shakir SA "A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil." Int J Clin Pharmacol Ther 40 (2002): 422-3</p><p id="ref_41">41. "Viagra and loss of vision." Med Lett Drugs Ther 47 (2005): 49</p><p id="ref_42">42. Pomeranz HD,  Smith KH,  Hart WM Jr,  Egan RA "Sildenafil-associated nonarteritic anterior ischemic optic neuropathy." Ophthalmology 109 (2002): 584-7</p><p id="ref_43">43. Zrenner E "No cause for alarm over retinal side-effects of sildenafil." Lancet 353 (1999): 340-1</p><p id="ref_44">44. Vobig MA, Klotz T, Staak M, BartzSchmidt KU, Engelmann U, Walter P "Retinal side-effects of sildenafil." Lancet 353 (1999): 375</p><p id="ref_45">45. Gandhi JS "Sildenafil-associated NAION." Ophthalmology 110 (2003): 1860-1; author reply 1861</p><p id="ref_46">46. Jagle H,  Jagle C,  Serey L, et al. "Visual short-term effects of viagra: double-blind study in healthy young subjects." Am J Ophthalmol 137 (2004): 842-9</p><p id="ref_47">47. Milman HA,  Arnold SB "Neurologic, psychological, and aggressive disturbances with sildenafil." Ann Pharmacother 36 (2002): 1129-34</p><p id="ref_48">48. Kassim AA, Fabry ME, Nagel RL "Acute priapism associated with the use of sildenafil in a patient with sickle cell trait." Blood 95 (2000): 1878-9</p><p id="ref_49">49. Goldmeier D,  Lamba H "Prolonged erections produced by dihydrocodeine and sildenafil." BMJ 324 (2002): 1555</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Cialis vs Viagra - What's the difference between them?</li>
<li>Is generic Viagra available in the U.S.?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about sildenafil</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>416 Reviews</li>
<li>Drug class: agents for pulmonary hypertension</li>
<li>FDA Alerts (13)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Sildenafil injection</li>
<li>Sildenafil &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Sildenafil Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Viagra, Revatio</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +4 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Erectile Dysfunction</li>
<li>Sexual Dysfunction, SSRI Induced</li>
<li>Pulmonary Hypertension</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to sildenafil: intravenous solution, oral powder for reconstitution, oral tablet</i></p><h3>General</h3><p>The most common adverse reactions reported in clinical trials are headache, flushing, dyspepsia, abnormal vision, nasal congestion, back pain, myalgia, nausea, dizziness, and rash.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Flushing (10%)</p><p><b>Uncommon</b> (0.1% to 1%): Heart rate increased, palpitations, tachycardia, hypertension, hypotension</p><p><b>Rare</b> (less than 0.1%): Myocardial infarction, atrial fibrillation, sudden cardiac death, ventricular arrhythmia, unstable angina</p><p><b>Frequency not reported</b>: Ventricular arrhythmia, sudden cardiac death, angina pectoris, AV block, tachycardia, palpitation, hypotension, postural hypotension, myocardial ischemia, cerebral thrombosis, cardiac arrest, heart failure, abnormal electrocardiogram, cardiomyopathy, shock</p><p><b>Postmarketing reports</b>: Serious cardiovascular, cerebrovascular, and vascular events, including myocardial infarction; sudden cardiac death; ventricular arrhythmia; cerebrovascular hemorrhage; transient ischemic attack; hypertension; subarachnoid, intracerebral, and pulmonary hemorrhage have been reported in temporal association with the use of this drug.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dyspepsia (up to 17%), diarrhea</p><p><b>Common</b> (1% to 10%): Nausea, vomiting, dry mouth, gastritis, gastroesophageal reflux disease, hemorrhoids, abdominal distension</p><p><b>Rare</b> (less than 0.1%): Oral hypoesthesia</p><p><b>Frequency not reported</b>: Glossitis, colitis, dysphagia, gastroenteritis, esophagitis, stomatitis, gingivitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Pain in extremity</p><p><b>Common</b> (1% to 10%): Back pain, myalgia</p><p><b>Frequency not reported</b>: Arthritis, arthrosis, myalgia, tendon rupture, tenosynovitis, bone pain, myasthenia, synovitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 28%)</p><p><b>Common</b> (1% to 10%): Dizziness, migraine, tremor, paresthesia, burning sensation</p><p><b>Uncommon</b> (0.1% to 1%): Somnolence, hypoesthesia</p><p><b>Rare</b> (less than 0.1%): Cerebrovascular accident, syncope</p><p><b>Frequency not reported</b>: Transient ischemic attack, seizure, seizure recurrence, ataxia, hypertonia, neuralgia, neuropathy, paresthesia, somnolence, reflexes decreased</p><p><b>Postmarketing reports</b>: Transient global amnesia<sup>[Ref]</sup></p><h3>Ocular</h3><p>This drug has lesser affinity for isoenzyme PDE6, an enzyme found in the retina.  This lower selectivity is thought to be the basis for abnormalities related to color vision observed with higher doses or plasma levels.</p><p></p><p>Nonarteritic anterior ischemic optic neuropathy developed in one eye within minutes to hours after ingestion of sildenafil.  Four of the five patients had no vascular risk factors for ischemic optic neuropathy.</p><p></p><p>-Abnormal Vision: Mild to moderate and transient, predominantly color tinge to vision, but also increased sensitivity to light, or blurred vision.</p><p>-Visual color distortions: Chloropsia, chromatopsia, cyanopsia, erythropsia and xanthopsia </p><p>-Lacrimation disorders: Dry eye, lacrimal disorder and lacrimation increased<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Abnormal vision (up to 11%)</p><p><b>Common</b> (1% to 10%): Visual color distortion, retinal hemorrhage, visual impairment, vision blurred, photophobia, chromatopsia, cyanopsia, eye irritation, ocular hyperemia</p><p><b>Uncommon</b> (0.1% to 1%): Conjunctival disorders, eye disorders, eye pain, lacrimation disorders, visual acuity reduced, diplopia, abnormal sensation in eye, photopsia, visual brightness, conjunctivitis</p><p><b>Rare</b> (less than 0.1%): Retinal hemorrhage, arteriosclerotic retinopathy, retinal disorder, glaucoma, visual field defect, myopia, asthenopia, vitreous floaters, iris disorder, mydriasis, halo vision, eye edema, eye swelling, eyelid edema, scleral discoloration</p><p><b>Frequency not reported</b>: Non-arteritic anterior ischemic optic neuropathy (NAION), retinal vascular occlusion, visual field defect, cataract<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Pharyngitis (18%), rhinitis</p><p><b>Common</b> (1% to 10%): Nasal congestion, epistaxis, cough</p><p><b>Uncommon</b> (0.1% to 1%): Sinus congestion</p><p><b>Rare</b> (less than 0.1%): Throat tightness, nasal edema, nasal dryness</p><p><b>Frequency not reported</b>: Asthma, dyspnea, laryngitis, pharyngitis, sinusitis, bronchitis, sputum increased, cough increased<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash, alopecia, erythema, night sweats </p><p><b>Frequency not reported</b>: Steven-Johnson syndrome (SJS), toxic epidermal necrolysis(TEN), urticaria, herpes simplex, pruritus, sweating, skin ulcer, contact dermatitis, exfoliative dermatitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia</p><p><b>Frequency not reported</b>: Leukopenia</p><p><b>Postmarketing reports</b>: In patients with pulmonary arterial hypertension (secondary to sickle cell disease) taking Revatio (R), vaso-occlusive crises requiring hospitalization were more commonly reported.  The clinical relevance of this finding in male patients treated with sildenafil for erectile dysfunction is unknown.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Fluid retention</p><p><b>Frequency not reported</b>: Thirst, edema, gout, unstable diabetes, hyperglycemia, hyperuricemia, hypoglycemic reaction, hypernatremia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Cellulitis, influenza, bronchitis, sinusitis, rhinitis, gastroenteritis, vertigo, pyrexia</p><p><b>Uncommon</b> (0.1% to 1%): Tinnitus, chest pain, fatigue, gynecomastia</p><p><b>Rare</b> (less than 0.1%): Deafness, irritability</p><p><b>Frequency not reported</b>: Sudden hearing loss, edema, face edema, peripheral edema, pain, chills accidental fall, accidental injury<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, anxiety</p><p><b>Frequency not reported</b>: Abnormal dreams, depression<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Penile hemorrhage, hematospermia</p><p><b>Frequency not reported</b>: Priapism, prolonged erection, increased erection, cystitis, nocturia, urinary frequency, urinary incontinence, abnormal ejaculation, genital edema, anorgasmia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Hematuria<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Hypersensitivity reactions, including rash and urticaria<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Liver function tests abnormal<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Viagra (sildenafil)." Pfizer US Pharmaceuticals, New York, NY. </p><p id="ref_3">3. "Product Information. Revatio (sildenafil)." Pfizer U.S. Pharmaceuticals Group, New York, NY. </p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_5">5. Conti CR, Pepine CJ, Sweeney M "Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease." Am J Cardiol 83 (1999): c29-34</p><p id="ref_6">6. Malozowski S, Sahlroot JT "Hemodynamic effects of sildenafil." N Engl J Med 343 (2000): 967-8</p><p id="ref_7">7. Arruda-Olson AM,  Pellikka PA "Appropriate use of exercise testing prior to administration of drugs for treatment of erectile dysfunction." Herz 28 (2003): 291-7</p><p id="ref_8">8. Tran D,  Howes LG "Cardiovascular safety of sildenafil." Drug Saf 26 (2003): 453-60</p><p id="ref_9">9. Stanopoulos I,  Hatzichristou D,  Tryfon S,  Tzortzis V,  Apostolidis A,  Argyropoulou P "Effects of sildenafil on cardiopulmonary responses during stress." J Urol 169 (2003): 1417-21</p><p id="ref_10">10. Kloner RA "Cardiovascular risk and sildenafil." Am J Cardiol 86 (2000): f57-61</p><p id="ref_11">11. Feenstra J, vanDriePierik RJHM, Lacle CF, Stricker BHC "Acute myocardial infarction associated with sildenafil." Lancet 352 (1998): 957-8</p><p id="ref_12">12. McLeod AL,  McKenna CJ,  Northridge DB "Myocardial infarction following the combined recreational use of Viagra and cannabis." Clin Cardiol 25 (2002): 133-4</p><p id="ref_13">13. Kloner RA, Zusman RM "Cardiovascular effects of sildenafil citrate and recommendations for its use." Am J Cardiol 84 (1999): n11-7</p><p id="ref_14">14. Webster LJ,  Michelakis ED,  Davis T,  Archer SL "Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial." Arch Intern Med 164 (2004): 514-20</p><p id="ref_15">15. Khandheria BK "Erection, erectile dysfunction: what has heart got to do with it?" Herz 28 (2003): 275-6</p><p id="ref_16">16. Zusman RM "Cardiovascular data on sildenafil citrate - Introduction." Am J Cardiol 83 (1999): c1-2</p><p id="ref_17">17. Jackson G "Treatment of erectile dysfunction in patients with cardiovascular disease : guide to drug selection." Drugs 64 (2004): 1533-45</p><p id="ref_18">18. Arruda-Olson AM,  Mahoney DW,  Nehra A,  Leckel M,  Pellikka PA "Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial." JAMA 287 (2002): 719-25</p><p id="ref_19">19. Moreira SG, Brannigan RE, Spitz A, Orejuela FJ, Lipshultz LI, Kim ED "Side-effect profile of sildenafil citrate (Viagra) in clinical practice." Urology 56 (2000): 474-6</p><p id="ref_20">20. McMahon CG, Smali R, Johnson H "Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction." J Urol 164 (2000): 1192-6</p><p id="ref_21">21. Brindis RG,  Kloner RA "Sildenafil in patients with cardiovascular disease." Am J Cardiol 92(9 Suppl) (2003): 26-36</p><p id="ref_22">22. Israilov S,  Baniel J,  Shmueli J, et al. "Treatment program for erectile dysfunction in patients with cardiovascular diseases." Am J Cardiol 93 (2004): 689-93</p><p id="ref_23">23. Montorsi F, McDermott TED, Morgan R, Olsson A, Schultz A, Kirkeby HJ, Osterloh IH "Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies." Urology 53 (1999): 1011-8</p><p id="ref_24">24. Goldenberg MM "Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction." Clin Ther 20 (1998): 1033-48</p><p id="ref_25">25. Zusman RM, Morales A, Glasser DB, Osterloh IH "Overall cardiovascular profile of sildenafil citrate." Am J Cardiol 83 (1999): c35-44</p><p id="ref_26">26. Egan RA,  Pomeranz H "Transient ischemic attack an stroke associated with sildenafil (Viagra) use." Neurology 59 (2002): 293-4</p><p id="ref_27">27. Awan GM, Calderon E, Dawood G, Alpert MA "Acute, symptomatic atrial fibrillation after sildenafil citrate therapy in a patient with hypertrophic obstructive cardiomyopathy." Am J Med Sci 320 (2000): 69-71</p><p id="ref_28">28. Bocchi EA,  Guimaraes G,  Mocelin A,  Bacal F,  Bellotti G,  Ramires JF "Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction." Circulation 106 (2002): 1097-103</p><p id="ref_29">29. Dunn N "Cardiovascular events in users of sildenafil - Paper does not provide any reassurance." Br Med J 323 (2001): 50-1</p><p id="ref_30">30. Bosch X "Sildenafil's effects extended to additional organs." Lancet 355 (2000): 631</p><p id="ref_31">31. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA "Oral sildenafil in the treatment of erectile dysfunction." N Engl J Med 338 (1998): 1397-404</p><p id="ref_32">32. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ "Sildenafil, a novel effective oral therapy for male erectile dysfunction." Br J Urol 78 (1996): 257-61</p><p id="ref_33">33. PadmaNathan H, Steers WD, Wicker PA "Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: A double-blind, placebo-controlled study of 329 patients." Int J Clin Pract 52 (1998): 375-9</p><p id="ref_34">34. Bortolotti M, Mari C, Lopilato C, Porrazzo G, Miglioli M "Effects of sildenafil on esophageal motility of patients with idiopathic achalasia." Gastroenterology 118 (2000): 253-7</p><p id="ref_35">35. Gilad R,  Lampl Y,  Eshel Y,  Sadeh M "Tonic-clonic seizures in patients taking sildenafil." BMJ 325 (2002): 869</p><p id="ref_36">36. Savitz SA,  Caplan LR "Transient global amnesia after sildenafil (Viagra) use." Neurology 59 (2002): 778</p><p id="ref_37">37. Marmor MF "Sildenafil (Viagra) and ophthalmology." Arch Ophthalmol 117 (1999): 518-9</p><p id="ref_38">38. Egan R, Pomeranz H "Sildenafil (Viagra) associated anterior ischemic optic neuropathy." Arch Ophthalmol 118 (2000): 291-2</p><p id="ref_39">39. Vobig MA "Retinal side-effects of sildenafil." Lancet 353 (1999): 1442</p><p id="ref_40">40. Boshier A,  Pambakian N,  Shakir SA "A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil." Int J Clin Pharmacol Ther 40 (2002): 422-3</p><p id="ref_41">41. "Viagra and loss of vision." Med Lett Drugs Ther 47 (2005): 49</p><p id="ref_42">42. Pomeranz HD,  Smith KH,  Hart WM Jr,  Egan RA "Sildenafil-associated nonarteritic anterior ischemic optic neuropathy." Ophthalmology 109 (2002): 584-7</p><p id="ref_43">43. Zrenner E "No cause for alarm over retinal side-effects of sildenafil." Lancet 353 (1999): 340-1</p><p id="ref_44">44. Vobig MA, Klotz T, Staak M, BartzSchmidt KU, Engelmann U, Walter P "Retinal side-effects of sildenafil." Lancet 353 (1999): 375</p><p id="ref_45">45. Gandhi JS "Sildenafil-associated NAION." Ophthalmology 110 (2003): 1860-1; author reply 1861</p><p id="ref_46">46. Jagle H,  Jagle C,  Serey L, et al. "Visual short-term effects of viagra: double-blind study in healthy young subjects." Am J Ophthalmol 137 (2004): 842-9</p><p id="ref_47">47. Milman HA,  Arnold SB "Neurologic, psychological, and aggressive disturbances with sildenafil." Ann Pharmacother 36 (2002): 1129-34</p><p id="ref_48">48. Kassim AA, Fabry ME, Nagel RL "Acute priapism associated with the use of sildenafil in a patient with sickle cell trait." Blood 95 (2000): 1878-9</p><p id="ref_49">49. Goldmeier D,  Lamba H "Prolonged erections produced by dihydrocodeine and sildenafil." BMJ 324 (2002): 1555</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Cialis vs Viagra - What's the difference between them?</li>
<li>Is generic Viagra available in the U.S.?</li>
</ul><h2>More about sildenafil</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>416 Reviews</li>
<li>Drug class: agents for pulmonary hypertension</li>
<li>FDA Alerts (13)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Sildenafil injection</li>
<li>Sildenafil &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Sildenafil Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +4 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Erectile Dysfunction</li>
<li>Sexual Dysfunction, SSRI Induced</li>
<li>Pulmonary Hypertension</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>